Background: Metabolic and endocrine disorders are related to a significant proportion of mortality and morbidity seen in the child population globally. The disorders and associated comorbidities affecting various body organs including inner ear functions include diabetes mellitus, growth hormone deficiency, childhood obesity, precocious puberty, etc. Aims: The present clinical trial was carried out to assess high-frequency hearing, associated tinnitus and vertigo in children with endocrine disorders including growth hormone deficiency, precocious puberty, type 1 diabetes mellitus, obesity and idiopathic short stature. Materials and Methods: 120 subjects having a growth hormone deficiency, precocious puberty, type 1 diabetes mellitus, obesity and/or idiopathic short stature, and 32 healthy children were evaluated with a complete otolaryngologic examination followed by otoscopic ear examination, tympanometry, vertigo, and tinnitus. The collected data were subjected to statistical evaluation and results were formulated. Results: PTA˃20dB was seen in 2.5% (n=3) subjects, HFA ˃20dB was seen in 5% (n=6), PTA and HFA ˃20dB in 5% (n=6) subjects (p= 1.000, 0.465, and 1.000). 18.6% (n=19) had tinnitus, and 8.82% (n=9) had vertigo. Presence of vertigo and tinnitus in study subjects with ISS seen in 22.7% (p=0.04). Vertigo with PTA and HFA value ˃20dB was seen in 3.84% (n=1) subject with GHD, 5.88% (n=2) with Type1 DM, 4% (n=1) with obesity, and 3.06% (n=3) subjects in whole experimental group. Conclusion: Within its limitations, the present study concludes that endocrine diseases manifested in childhood can lead to alterations in the inner ear with poorly understood aetiology. However, the study suggests a balance examination and thorough hearing examination be done in all children visiting endocrinology clinics to detect and treat any associated abnormality at an early stage.